Cobalt (II) ion complex as well as preparation method and application thereof
Cobalt (II) ion complex {Co(H2O)2[H(4-CPCA)]2}·2H2O was prepared by coordinating the pyridazine carboxylic acid derivative H2 (4-CPCA) with cobalt (II) ions. , forming a three-dimensional supramolecular grid structure, solving the problem of insufficient antibacterial activity of existing pyridazine derivatives, and achieving effective inhibition of E. coli and Pseudomonas aeruginosa.
Patent Information
- Application Number
- CN202311200111.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-18
- Publication Date
- 2024-12-06
AI Technical Summary
The existing pyridazine derivatives have limited application effects in the antibacterial field, especially when fighting bacteria such as E. coli and Pseudomonas aeruginosa, the antibacterial activity is insufficient.
Cobalt (II) ion complex {Co(H2O)2[H(4-CPCA)]2 is prepared by the solvothermal reaction method using the pyridazine carboxylic acid derivative H2 (4-CPCA)]2 }·2H2O forms a zero-dimensional single-molecular structure and forms a three-dimensional supramolecular grid structure through intermolecular hydrogen bonds to enhance its antibacterial activity.
The prepared cobalt (II) ion complex has good dispersion in solution and has strong antibacterial activity. It can effectively inhibit E. coli and Pseudomonas aeruginosa and is suitable for the antibacterial field.
Smart Images

Figure CN119081132A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of development of antibacterial active substances, and in particular to a cobalt (II) ion complex and a preparation method and application thereof. Background Art
[0002] Pyridazine (C4H4N2) is an important cyclic amine compound, containing two ortho nitrogen atoms, with active chemical properties. It is a commonly used synergistic group in chemical structure design and is widely used in the pharmaceutical field. Pyridazine can not only be used as a pharmaceutical intermediate, but also as one of the indispensable fine chemical raw materials. Based on the different types, positions and connection modes of the substituent groups on the pyridazine ring, pyridazine derivatives also show a variety of chemical structures and have biological activities such as antibacterial and anticancer. Pyridazine carboxylic acid derivatives are carboxylic acid groups introduced on the pyridazine ring. They have both the structural characteristics of the pyridazine ring and the characteristics of the carboxyl group. They belong to the nitrogen-containing heterocyclic aromatic carboxylic acid ligands and are typical nitrogen-containing heterocyclic and oxygen-containing carboxylic acid ligands. The coordination mode is highly predictable, the structural types are rich and diverse, and there are many coordination sites for the synthesis of metal organic frameworks. The formed metal complexes have special physical and chemical properties and biological activities and can be widely used in the pharmaceutical field.
[0003] Among the many methods for regulating the structure of complexes, ligand regulation is a relatively simple and controllable method that has been studied more. If a carboxylic acid group is introduced on the nitrogen atom of the pyridazine ring, combined with the unique biological activity of pyridazine itself, a special structure with stronger antibacterial activity may be obtained. Based on this, a pyridazine carboxylic acid derivative [H2(4-CPCA)] was selected as an organic ligand to coordinate with the transition metal cobalt, and finally a cobalt (II) complex constructed by a pyridazine carboxylic acid derivative was obtained. Escherichia coli and Pseudomonas aeruginosa were used as test bacteria to evaluate the antibacterial properties of the complex. Summary of the invention
[0004] The invention provides a cobalt (II) ion complex and a preparation method and application thereof. A cobalt (II) ion complex is prepared, and the chemical expression of a single molecule is {Co(H2O)2[H(4-CPCA)]2}·2H2O. Cobalt (II) is used as a central ion. The cobalt (II) ion coordinates with the carboxyl oxygen and the carbonyl oxygen in H2(4-CPCA) to form a zero-dimensional single molecule structure. Further, under the action of intermolecular hydrogen bonds, the cobalt (II) ion complex forms a three-dimensional supramolecular grid structure. The cobalt (II) ion complex has good dispersibility in a solution and strong antibacterial activity, and can be applied in the antibacterial field.
[0005] In order to solve the above technical problems, the present invention provides a cobalt (II) ion complex, the chemical expression of the cobalt (II) ion complex is {Co(H2O)2[H(4-CPCA)]2}·2H2O.
[0006] The present invention also provides a method for preparing the above-mentioned cobalt (II) ion complex, comprising the following steps:
[0007] S1. Adding cobalt salt and H2(4-CPCA) into DMA solvent and mixing them evenly to obtain a mixed solution, adjusting the pH value of the mixed solution to 3.23-3.58, and then reacting the mixed solution at 70° C. for 72 hours to obtain a reaction product;
[0008] S2. Cooling the reaction product obtained in S1 to crystallize to obtain a crystallized product, and washing, filtering and drying the crystallized product in sequence to obtain a cobalt (II) ion complex.
[0009] According to the method for preparing a cobalt (II) ion complex provided by the present invention, the cobalt salt in S1 is any one of cobalt nitrate hexahydrate, cobalt sulfate or cobalt chloride.
[0010] According to the method for preparing a cobalt (II) ion complex provided by the present invention, the H2(4-CPCA) in S1 is 1-(4-carboxyphenyl-4-oxopyridazine)-3-carboxylic acid, and the structural formula of the H2(4-CPCA) is:
[0011]
[0012] According to the preparation method of the cobalt (II) ion complex provided by the present invention, the molar ratio of the cobalt salt and H2 (4-CPCA) in S1 is 0.5 mmol: 0.25 mmol, and the amount of DMA solvent used is 2 mL
[0013] According to the method for preparing a cobalt (II) ion complex provided by the present invention, the solution for adjusting the pH in S1 is a nitric acid solution, and the concentration of the nitric acid solution is 0.3 mol / L.
[0014] According to the method for preparing the cobalt (II) ion complex provided by the present invention, the filtration in S2 is reduced pressure filtration, and the drying condition is: constant temperature drying in an oven at 70° C. for 3 hours.
[0015] The present invention also provides an application of the cobalt (II) ion complex, and the cobalt (II) ion complex can be applied in the field of antibacterial.
[0016] The cobalt (II) ion complex of the present invention takes cobalt (II) as the central ion, forms a zero-dimensional single-molecule structure by connecting adjacent water molecules and H2 (4-CPCA) molecules, and then forms a three-dimensional supramolecular network structure through the action of hydrogen bonds between molecules.
[0017] The cobalt (II) ion complex crystal of the present invention belongs to the triclinic system and the P-1 space group, and the unit cell parameters are a=6.8831 (4), b=7.6016 (3), c=12.4375 (7), α=90.024 (4), β=104.239 (5), γ=90.007 (4),
[0018] Compared with the prior art, the present invention has the following advantages:
[0019] 1. The present invention adopts a one-pot solvent thermal reaction method to prepare a divalent cobalt ion complex, and the preparation method has the advantages of simple process, convenient operation, high yield and good reproducibility.
[0020] 2. The cobalt (II) ion complex of the present invention has good dispersibility in the solution and strong antibacterial activity, and can be applied in the field of antibacterial. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 is a single molecule image of the cobalt (II) ion complex prepared in Example 2;
[0022] Figure 2 is the three-dimensional supramolecular structure of the cobalt (II) ion complex prepared in Example 2;
[0023] Figure 3 is the IR graph of the cobalt (II) ion complex measured in Example 5;
[0024] Figure 4 is the XRD pattern of the cobalt (II) ion complex determined in Example 5;
[0025] Figure 5 These are the results of the diffusion of the four solutions on the filter paper of E. coli bacteria in Example 5;
[0026] Figure 6 These are the results of the diffusion of the four solutions in Example 5 on the filter paper of P. aeruginosa bacteria. DETAILED DESCRIPTION
[0027] Example 1
[0028] This embodiment provides a method for preparing H2(4-CPCA).
[0029] S1. Add 5 g of ethyl p-aminobenzoate and 250 mL of water to a 250 mL three-necked flask, stir evenly, and then slowly drop 30 mL of 1 mol / L concentrated hydrochloric acid into the three-necked flask at room temperature to obtain a reaction solution 1.
[0030] S2, dissolving 2.5 g of sodium nitrite in 50 mL of water to obtain a NaNO2 solution, and cooling the reaction solution obtained in S1 to a temperature below 0°C, then dripping the NaNO2 solution into the reaction solution, controlling the dripping rate to ensure that the temperature of the reaction solution is below 5°C, and after the dripping is completed, the reaction solution is reacted at a reaction temperature of 0 to 5°C for 30 minutes to obtain a reaction solution 2;
[0031] After the concentrated hydrochloric acid is added dropwise, milky white floccules will be produced in the reaction solution to obtain reaction solution 1. With the addition of NaNO2, the milky white floccules in reaction solution 1 gradually disappear, and a light yellow clear solution is generated. The temperature of the solution rises rapidly during the addition of NaNO2, and it must be added dropwise in batches. With the addition of NaNO2 solution, a yellow-white precipitate is generated in reaction solution 1 (if no precipitate is generated, it is placed in a cold well after the reaction and stirred rapidly. In order to fully precipitate the product, water can be added in an appropriate amount after the addition of the diazonium salt is completed;
[0032] S3, add 6g of sodium acetate, 40mL of water and 80mL of anhydrous ethanol to a 500mL three-necked flask in sequence, stir evenly and fully dissolve, add 5g of ethyl acetoacetate to obtain reaction solution 3, lower the temperature of reaction solution 3 to -3°C, then slowly drop reaction solution 2 obtained in S2 into reaction solution 3, a large amount of yellow solid precipitates during the dropwise addition, react at a reaction temperature of 0°C for 2h, filter to obtain a yellow solid filter cake, wash the filter cake with water until neutral and dry at room temperature to obtain 4.8g of (trans)-4-[2-(1-ethoxy-1,3-dioxobutane-2-ylidene)hydrazino]ethyl benzoate, the yield is 90%;
[0033] The obtained (trans)-4-[2-(1-ethoxy-1,3-dioxobutane-2-ylidene)hydrazino]benzoic acid ethyl ester is a cis-trans isomer, and two spots can be seen in the thin layer. Its melting point is low, and the heating drying method cannot be used;
[0034] S4, add 5g of (trans)-4-[2-(1-ethoxy-1,3-dioxobutane-2-ylidene)hydrazine] ethyl benzoate obtained in S3 and 25mL of toluene to another three-necked flask with a volume of 250mL, stir evenly and fully dissolve, then add 3.8g of DMF-DMA (N,N-dimethylformamide dimethyl acetal) to obtain reaction solution 4, and react the reaction solution 4 at a reaction temperature of 85°C for 3h. During the reaction, the reaction solution 4 gradually turns into a red-black solution, and methanol bubbles escape. After the reaction, the reaction solution 4 is cooled to room temperature and the toluene solvent is evaporated. The precipitated solid is gray during the evaporation process. After the toluene solvent is completely evaporated, the precipitated solid turns light yellow. If the color of the precipitated solid is very dark, 5mL of toluene solvent can be added to the reaction solution 4, and then pulping and suction filtration are performed in sequence to obtain 4.3g of 1-[4-(ethoxycarbonyl)phenyl]-4-oxo-1,4-dihydropyridazine-3-carboxylic acid ethyl ester, with a yield of 85.4%;
[0035] The temperature should not be too high during stirring, otherwise spraying may occur. No obvious intermediates were observed on the spot plate during the reaction. Ethyl (trans)-4-[2-(1-ethoxy-1,3-dioxobutane-2-ylidene)hydrazino]benzoate underwent ester exchange during the reaction with DMF-DMA.
[0036] The mass spectrum of the final product, 1-[4-(ethoxycarbonyl)phenyl]-4-oxo-1,4-dihydropyridazine-3-carboxylic acid ethyl ester, has a weak response of ethyl ester. In addition to the main spot, there are also virtual spots on the thin layer spot plate of the product of this step. After hydrolysis, there is only one spot. The miscellaneous spots are the ethyl ester product.
[0037] S5, add 1.8g of sodium hydroxide and 80mL of water to a new three-necked flask with a volume of 250mL, stir evenly and fully dissolve, then add 5g of 1-[4-(ethoxycarbonyl)phenyl]-4-oxo-1,4-dihydropyridazine-3-carboxylic acid ethyl ester obtained in S4 to obtain reaction solution 5, which is a light yellow suspension. The reaction solution 5 is heated to a reaction temperature of 50°C and reacts for 1h until the reaction is complete, then the reaction solution 5 is cooled to room temperature, and the pH value of the reaction solution 5 is adjusted to 2 with 6mol / L hydrochloric acid under ice bath conditions. A large amount of white solid is precipitated in the reaction solution 5, which is fully stirred for 2h and then filtered, washed with a large amount of water until the white solid is neutral, and then dried to obtain 4.8g of 1-(4-carboxyphenyl-4-oxopyridazine)-3-carboxylic acid, i.e., H2(4-CPCA), with a yield of 89.8%;
[0038] When adjusting the pH value, the white solid powder precipitated is too fine and sticky. Water can be added to the three-necked flask to dilute it. If the final product 1-(4-carboxyphenyl-4-oxopyridazine)-3-carboxylic acid is sticky, ethanol beating can be considered to improve the situation and increase the drying rate.
[0039] Example 2
[0040] This embodiment provides a method for preparing a cobalt (II) ion complex.
[0041] S1. 0.5 mmol of cobalt nitrate hexahydrate and 0.25 mmol of H2(4-CPCA) were added to a glass scintillation vial containing 2 mL of DMA solvent (N, N'-dimethylacetamide) and mixed evenly to obtain a mixed solution. The pH value of the mixed solution was adjusted to 3.23 with a 0.3 mol / L nitric acid solution. The mixed solution was subjected to a solvothermal isothermal reaction at 70° C. for 72 h to obtain a reaction product.
[0042] S2. Cool the reaction product obtained in S1 and crystallize it to obtain a crystallization product. Rinse the crystallization product with deionized water, and then filter it under reduced pressure to obtain transparent block crystals. Place the transparent block crystals in an oven at a temperature of 70° C. and keep the temperature constant for 3 hours to obtain a cobalt (II) ion complex. The molecular formula of the cobalt (II) ion complex is {Co(H2O)2[H(4-CPCA)]2}·2H2O, and the yield is about 72.3%.
[0043] The cobalt (II) ion complex prepared in this embodiment has cobalt (II) as the central ion. The cobalt (II) ion forms a zero-dimensional single-molecule structure by coordinating with the carboxyl oxygen and carbonyl oxygen in H2 (4-CPCA). Then, under the action of intermolecular hydrogen bonds, the cobalt (II) ion complex forms a three-dimensional supramolecular grid structure.
[0044] Example 3
[0045] This embodiment provides a method for preparing a cobalt (II) ion complex.
[0046] S1. 0.5 mmol of cobalt sulfate and 0.25 mmol of H2(4-CPCA) were added to a glass scintillation vial containing 2 mL of DMA solvent and mixed evenly to obtain a mixed solution. The pH value of the mixed solution was adjusted to 3.12 with a 0.3 mol / L nitric acid solution. The mixed solution was subjected to a solvothermal isothermal reaction at 70° C. for 72 h to obtain a reaction product.
[0047] S2. The reaction product obtained in S1 is cooled and crystallized to obtain a crystallized product, the crystallized product is rinsed with deionized water, and then filtered under reduced pressure to obtain orange-red cluster crystals, and the transparent block crystals are placed in an oven at a temperature of 70° C. for 3 hours to obtain a cobalt (II) ion complex with a yield of about 74.6%.
[0048] Example 4
[0049] This embodiment provides a method for preparing a cobalt (II) ion complex.
[0050] S1. 0.5 mmol of cobalt chloride and 0.25 mmol of H2(4-CPCA) were added to a glass scintillation vial containing 2 mL of DMA solvent and mixed evenly to obtain a mixed solution. The pH value of the mixed solution was adjusted to 3.51 with a 0.3 mol / L nitric acid solution. The mixed solution was subjected to a solvothermal isothermal reaction at 70° C. for 72 h to obtain a reaction product.
[0051] S2. Cool the reaction product obtained in S1 and crystallize it to obtain a crystallized product. Rinse the crystallized product with deionized water, and then filter it under reduced pressure to obtain transparent block crystals. Place the transparent block crystals in an oven at a temperature of 70° C. and keep the temperature constant for 3 hours to obtain a cobalt (II) ion complex with a yield of about 70.2%.
[0052] Example 5
[0053] The cobalt (II) ion complex prepared in Example 2 was characterized.
[0054] (1) Crystal structure determination of cobalt (II) ion complex
[0055] A single crystal with a size of 0.200×0.230×0.240 mm was selected under a microscope and X-ray diffraction experiments were carried out at room temperature.
[0056] Diffraction data were collected on a Bruker-Apex II X-ray single crystal diffractometer using Mo-Kα radiation monochromatized by a graphite monochromator. Diffraction points were collected in ω-2θ scanning mode. All data were corrected by factors and empirical absorption. The crystal structure was solved by a direct method using a program. Hydrogen atoms were determined by difference Fourier synthesis and fixed in the calculated optimal positions. All non-hydrogen atoms and their anisotropic thermal parameters were corrected by the full matrix least squares method based on SHELX-97 program. The main crystallographic determination data of the cobalt (II) ion complex are shown in Table 1. The important bond length and bond angle data of the cobalt (II) ion complex are shown in Table 2. The crystal structure is shown in Figure 1 As shown, the three-dimensional supramolecular structure of the polymer is observed from the b-axis direction, as Figure 2 shown.
[0057] Table 1
[0058]
[0059]
[0060] Table 2
[0061]
[0062] (2) Infrared (IR) spectral characterization
[0063] Figure 3 This is the IR spectrum of the cobalt (II) ion complex with H2 (4-CPCA). The infrared spectrum of the sample collected data from 500 to 4000 cm -1 , using KBr pellets, Figure 3 It can be seen that 1507~1598cm -1 The three peaks between are the stretching vibration peaks of the benzene ring, 3600cm-1 The peak at 1654 cm is the stretching vibration peak of the OH bond in the water molecule. -1 The peak is the stretching vibration peak of the carbonyl group.
[0064] (3) Phase purity characterization of cobalt (II) ion complexes
[0065] The powder XRD characterization results of the cobalt (II) ion complex using a Bruker / D8Advance X-ray diffractometer showed that it had reliable phase purity, such as Figure 4 shown.
[0066] (4) Antibacterial properties of cobalt (II) ion complexes
[0067] 8 g of tryptone, 5 g of yeast extract powder, 10 g of sodium chloride and 30 g of agar were added to 1 L of deionized water, and the LB medium was prepared by sterilizing at 121° C. for 30 min using a high pressure sterilizer with model LDZF-75L purchased from Shanghai Shen'an Medical Device Factory. The LB medium was poured into a sterilized culture dish while hot under a sterile environment, cooled and solidified for standby use, and the bacterial mother solution was dipped with an inoculation loop and spread on the LB medium, followed by incubation in an incubator at 37° C. for 12 h. After the incubation was completed, a single colony was picked out from the cultured bacteria, transferred to a test tube containing 5 mL of culture solution, and cultured at 37° C. for 12 h with constant temperature shaking, and then placed in a refrigerator for standby use;
[0068] The antibacterial properties of the cobalt (II) ion complex materials were studied by the filter paper diffusion method using the suspension of Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa stored in a -80℃ refrigerator as test bacteria.
[0069] The required experimental materials were sterilized at 121°C for 20 min using a high pressure sterilizer, and the prepared cobalt (II) ion complex material was prepared into a complex solution with a mass concentration of 25 mg / mL using a sterilized DMSO (dimethyl sulfoxide) solvent for standby use. The same concentration of H2 (4-CPCA) solution, metal Co solution and pure DMSO solution were prepared according to the above method as a control experimental group;
[0070] The activated E. coli and P. aeruginosa bacteria were diluted with sterilized ultrapure water until the bacterial colony was 5×10 7 cfu / mL, take 400 μL of the diluted bacterial solution and evenly spread it on the sterilized solid LB medium, and set a filter paper with a diameter of 6 mm on the surface of the medium, then take 8 μL of the prepared complex solution, control material solution and DMSO pure solvent and drop them on the filter paper, set up 6 groups of experiments in parallel, and culture them in a 37℃ constant temperature and light incubator for 12 hours to observe the results;
[0071] Figure 5 and Figure 6 The filter paper diffusion results of different solutions on E. coli and P. aeruginosa bacteria (A, B, C, and D correspond to solvent DMSO, metal Co, H2 (4-CPCA), and cobalt (II) ion complex, respectively). It can be seen from the size of the inhibition zone that the complex solution, H2 (4-CPCA) solution, and metal cobalt solution have inhibitory effects on the two test bacteria, E. coli and P. aeruginosa, and at the same concentration, the inhibitory activity of the complex solution on the test bacteria is significantly greater than that of the H2 (4-CPCA) solution and the metal cobalt solution. The specific statistical results of the inhibition zone diameter are shown in Table 3.
[0072] Table 3
[0073]
[0074] The above is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent change made to the above embodiment according to the technical essence of the invention still falls within the protection scope of the technical solution of the present invention.
Claims
1. A cobalt (II) ion complex, It is characterized in that The chemical formula of the cobalt (II) ion complex is {Co(H 2 O) 2 [H(4-CPCA)] 2 }·2H 2 O.
2. A method for preparing the cobalt (II) ion complex as claimed in claim 1, It is characterized in that The following steps are involved: S1, cobalt salt and H 2 (4-CPCA) was added to the DMA solvent and mixed evenly to obtain a mixed solution. After the pH value of the mixed solution was adjusted to 3.23-3.58, the mixed solution was subjected to constant temperature reaction at 70° C. for 72 hours to obtain a reaction product. S2. Cooling the reaction product obtained in S1 to crystallize to obtain a crystallized product, and washing, filtering and drying the crystallized product in sequence to obtain a cobalt (II) ion complex.
3. The method for preparing the cobalt (II) ion complex according to claim 2, It is characterized in that The cobalt salt in S1 is any one of cobalt nitrate hexahydrate, cobalt sulfate or cobalt chloride.
4. The method for preparing the cobalt (II) ion complex according to claim 2, It is characterized in that S1H 2 (4-CPCA) is 1-(4-carboxyphenyl-4-oxopyridazine)-3-carboxylic acid, wherein H 2 The structural formula of (4-CPCA) is:
5. The method for preparing the cobalt (II) ion complex according to claim 2, It is characterized in that The cobalt salt and H 2 The molar ratio of (4-CPCA) was 0.5 mmol:0.25 mmol, and the amount of DMA solvent used was 2 mL.
6. The method for preparing the cobalt (II) ion complex according to claim 2, It is characterized in that The solution for adjusting pH in S1 is a nitric acid solution, and the concentration of the nitric acid solution is 0.3 mol / L.
7. The method for preparing the cobalt (II) ion complex according to claim 2, It is characterized in that The filtration in S2 is reduced pressure filtration, and the drying condition is: constant temperature drying in an oven at 70° C. for 3 hours.
8. Use of the cobalt (II) ion complex as claimed in claim 1, It is characterized in that The cobalt (II) ion complex can be applied to the field of antibacterial.
Citation Information
Cited By
Praseodymium (III) metal organic framework crystalline material as well as preparation method and application thereof
CN120365581A
